[1] ESPAGNOLLE N, GUILLOTON F, DESCHASEAUX F, et al. CD146 expression on mesenchymal stem cells is associated with their vascular smooth muscle commitment. J Cell Mol Med. 2014; 18(1):104-114.
[2] CAO D, MA F, OUYANG S, et al. Effects of macrophages and CXCR2 on adipogenic differentiation of bone marrow mesenchymal stem cells. J Cell Physiol. 2019;234(6):9475-9485.
[3] WU Z, LU H, YAO J, et al. GABARAP promotes bone marrow mesenchymal stem cells-based the osteoarthritis cartilage regeneration through the inhibition of PI3K/AKT/mTOR signaling pathway. J Cell Physiol. 2019;234(11):21014-21026.
[4] CHANDA D, KUMAR S, PONNAZHAGAN S. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. J Cell Biochem. 2010;111(2):249-257.
[5] NING J, LI C, LI H, et al. Bone marrow mesenchymal stem cells differentiate into urothelial cells and the implications for reconstructing urinary bladder mucosa. Cytotechnology. 2011; 63(5):531-539.
[6] WEI ZJ, FAN BY, LIU Y, et al. MicroRNA changes of bone marrow-derived mesenchymal stem cells differentiated into neuronal-like cells by Schwann cell-conditioned medium. Neural Regen Res. 2019;14(8):1462-1469.
[7] 卫荣,温欣,王莉,魏志勇.中药补肾活血方提取物促进SD大鼠骨髓间充质干细胞增殖作用的最佳浓度[J].中国组织工程研究,2019,23(5): 691-696.
[8] 高月彩,李蒙,李瑞玉,等.补肾中药在干细胞培养与移植中的干预作用[J].中国组织工程研究,2013,17(14):2609-2616.
[9] DOMINICI M, LE BLANC K, MUELLER I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.
[10] YIN Q, JIN P, LIU X, et al. SDF-1α inhibits hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways. Mol Biol Rep. 2011; 38(1): 9-16.
[11] ZENG X, YU SP, TAYLOR T, et al. Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis. Stem Cell Res. 2012;8(3):357-367.
[12] LI GC, QIN XL, SONG HH, et al. Upregulated microRNA-15b alleviates ovarian cancer through inhitbition of the PI3K/Akt pathway by targeting LPAR3. J Cell Physiol. 2019;234(12): 22331-22342.
[13] MA S, LIU T, XU L, et al. Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway. J Cell Physiol. 2019;234(12):22400-22410.
[14] VASUDEVAN KM, BARBIE DA, DAVIES MA, et al. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell. 2009;16(1):21-32.
[15] MABUCHI S, KURODA H, TAKAHASHI R, et al. The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer. Gynecol Oncol. 2015;137(1):173-9.
[16] LU PW, LI L, WANG F, et al. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway. J Cell Physiol. 2019;234(2):1904-1912.
[17] HONG X, HONG X, ZHAO H, et al. Knockdown of SRPX2 inhibits the proliferation, migration, and invasion of prostate cancer cells through the PI3K/Akt/mTOR signaling pathway. J Biochem Mol Toxicol. 2018:e22237.
[18] REHAN M, BAJOUH OS. Virtual screening of naphthoquinone analogs for potent inhibitors against the cancer-signaling PI3K/AKT/mTOR pathway. J Cell Biochem. 2018 Oct 8. doi: 10.1002/jcb.27100. [Epub ahead of print]
[19] 张丽梅,雷枭.归肾丸加减治疗卵巢早衰肾阴虚证的临床分析[J].中国实验方剂学杂志,2016,22(11):170-173.
[20] 马雪英.中药补肾方剂治疗卵巢早衰临床效果分析[J].新中医,2015, 47(5): 181-182.
[21] 孙松奇.归肾丸对多囊卵巢综合症的临床疗效分析[J].实用妇科内分泌杂志(电子版),2017,4(25):142,144.
[22] 韩璐,龚巍.归肾丸治疗多囊卵巢综合征治疗的临床疗效分析[J].中国实验方剂学杂志,2011,17(24):216-217.
[23] 何惠娟.归肾丸加减治疗肾虚型月经过少病38例临床观察[J].光明中医,2016,31(6):801-803.
[24] 刘敏.归肾丸加减治疗肾虚血瘀型月经过少病45例临床观察[J].泸州医学院学报,2014,37(4):398-400.
[25] 顾颖,许小凤.许小凤治疗青春期闭经经验[J].中医杂志,2011,52(9): 791-792.
[26] 卞琴,沈自尹,王拥军.骨髓间充质干细胞在中医理论中的归属[J].中国中医基础医学杂志,2011,17(7):794-797.
[27] 赖满香,廖利平,谭玮璐,等.“肾精-骨质疏松-骨髓间充质干细胞”理论探讨[J].中医杂志,2018,59(2):100-103.
[28] 谭峰. 补肾方剂诱导骨髓间充质干细胞增殖分化的理论和实验研究[D].南京:南京中医药大学,2011.
[29] JIN C, TIAN H, LI J, et al. Stem cell education for medical students at Tongji University: Primary cell culture and directional differentiation of rat bone marrow mesenchymal stem cells. Biochem Mol Biol Educ. 2018;46(2):151-154.
[30] BHUYAN DJ, SAKOFF J, BOND DR, et al. In vitro anticancer properties of selected Eucalyptus species. In Vitro Cell Dev Biol Anim. 2017;53(7):604-615.
|